Song Hongjian, Xie Guixiang, Li Yaowei, Hu Xiaowei, Yang Zongzheng, Zhao Yubo, Shi Qing, Li Haonan, Liu Ziyi, Yin Zhihao, Wang Ziqi, Tong Zhichao, Xu Wanhai
NHC Key Laboratory of Molecular Probe and Targeted Theranostics, The Second Affiliated Hospital of Harbin Medical University, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, 150001, China.
Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150001, China.
Discov Oncol. 2025 Apr 9;16(1):500. doi: 10.1007/s12672-025-02297-6.
Bladder cancer (BC) is characterized by high heterogeneity, with non-muscle-invasive (NMIBC) and muscle-invasive (MIBC) stages differing significantly in clinical behavior and outcomes. The transition from NMIBC to MIBC involves extensive tumor microenvironment (TME) remodeling, particularly in endothelial cells (ECs), which drive angiogenesis and modulate immune and extracellular matrix (ECM) interactions. However, the precise roles of ECs in this progression remain poorly defined.
Public single-cell RNA sequencing (scRNA-seq) datasets from 47 BC patients were analyzed to characterize endothelial cell heterogeneity and functional states across NMIBC and MIBC. Computational tools such as CellChat were applied to reconstruct cell-cell communication networks, focusing on pathways related to angiogenesis, immune crosstalk, and ECM remodeling.
Twelve major cell types were identified, with endothelial cells exhibiting distinct transcriptional profiles between NMIBC and MIBC. NMIBC-associated ECs promoted adhesion and migration through HMGB1 and CXCL12 signaling. In contrast, MIBC was enriched in an ADAM10 endothelial subset associated with vascular remodeling and activation of Wnt signaling via CTNNB1. Key ligand-receptor interactions highlighted the dynamic roles of ECs in TME modulation during BC progression.
This study reveals stage-specific endothelial cell phenotypes and signaling networks in BC. The identification of an MIBC-specific ADAM10 endothelial subset underscores its potential role in driving tumor progression and highlights opportunities for stage-adapted vascular-targeted therapies. These findings advance our understanding of BC pathogenesis and provide the foundation for novel therapeutic strategies.
膀胱癌(BC)具有高度异质性,非肌层浸润性膀胱癌(NMIBC)和肌层浸润性膀胱癌(MIBC)在临床行为和预后方面存在显著差异。从NMIBC向MIBC的转变涉及广泛的肿瘤微环境(TME)重塑,特别是在内皮细胞(ECs)中,内皮细胞驱动血管生成并调节免疫和细胞外基质(ECM)相互作用。然而,内皮细胞在这一进展过程中的精确作用仍不清楚。
分析来自47例BC患者的公开单细胞RNA测序(scRNA-seq)数据集,以表征NMIBC和MIBC中内皮细胞的异质性和功能状态。应用CellChat等计算工具重建细胞间通讯网络,重点关注与血管生成、免疫串扰和ECM重塑相关的信号通路。
确定了12种主要细胞类型,内皮细胞在NMIBC和MIBC之间表现出不同的转录谱。与NMIBC相关的内皮细胞通过HMGB1和CXCL12信号促进黏附和迁移。相比之下,MIBC中富含与血管重塑和通过CTNNB1激活Wnt信号相关的ADAM10内皮细胞亚群。关键的配体-受体相互作用突出了内皮细胞在BC进展过程中对TME调节的动态作用。
本研究揭示了BC中阶段特异性的内皮细胞表型和信号网络。MIBC特异性ADAM10内皮细胞亚群的鉴定强调了其在驱动肿瘤进展中的潜在作用,并突出了阶段适应性血管靶向治疗的机会。这些发现推进了我们对BC发病机制的理解,并为新的治疗策略提供了基础。